Cloned transgenic farm animals produce a bispecific antibody for T cell-mediated tumor cell killing
AUTOR(ES)
Grosse-Hovest, Ludger
FONTE
National Academy of Sciences
RESUMO
Complex recombinant antibody fragments for modulation of immune function such as tumor cell destruction have emerged at a rapid pace and diverse anticancer strategies are being developed to benefit patients. Despite improvements in molecule design and expression systems, the quantity and stability, e.g., of single-chain antibodies produced in cell culture, is often insufficient for treatment of human disease, and the costs of scale-up, labor, and fermentation facilities are prohibitive. The ability to yield mg/ml levels of recombinant antibodies and the scale-up flexibility make transgenic production in plants and livestock an attractive alternative to mammalian cell culture as a source of large quantities of biotherapeutics. Here, we report on the efficient production of a bispecific single-chain antibody in the serum of transgenic rabbits and a herd of nine cloned, transgenic cattle. The bispecific protein, designated r28M, is directed to a melanoma-associated proteoglycan and the human CD28 molecule on T cells. Purified from the serum of transgenic animals, the protein is stable and fully active in mediating target cell-restricted T cell stimulation and tumor cell killing.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=406432Documentos Relacionados
- NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses
- Human Monocyte Antibody-Dependent Cell-Mediated Cytotoxicity to Tumor Cells
- Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans.
- Spontaneous and antibody-dependent cell-mediated cytotoxicity by human T cell subpopulations.
- Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity.